2024 Global Histone Deacetylase Inhibitors Market Report: Key Drivers, Size, and Leading Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Histone Deacetylase Inhibitors Market for 2024-2033?
The histone deacetylase inhibitors market has experienced significant growth in recent years. It is projected to increase from $1.12 billion in 2023 to $1.20 billion in 2024, with a CAGR of 7.9%. Contributing factors include regulatory support, increasing prevalence of cancer, heightened funding for cancer research, expansion of therapeutic applications, and increased healthcare expenditure.
The histone deacetylase inhibitors market size is projected to experience robust growth in the next few years, reaching $1.64 billion in 2028 with a CAGR of 8.0%. This growth can be attributed to increasing investments in biotechnology, a growing elderly population, favorable regulatory approvals and expedited drug approval processes, improved drug delivery systems, and an expansion of therapeutic applications. Major trends include the integration of wearable devices for monitoring patient health, innovations in nanotechnology and drug delivery methods, advances in identifying and validating biomarkers, the use of artificial intelligence (AI) and machine learning, and next-generation sequencing.
What Drivers Are Enhancing the Histone Deacetylase Inhibitors Market’s Growth?
The increasing incidence of cancer is expected to accelerate the growth of the histone deacetylase inhibitors market moving forward. The rise in cancer cases is mainly due to aging populations, heightened exposure to risk factors such as tobacco, diet, and environmental pollutants, as well as improved diagnostic methods resulting in earlier and more frequent detection. Histone deacetylase inhibitors combat cancer by modifying chromatin structure, activating tumor suppressor genes, and suppressing oncogenes, which leads to cell cycle arrest and apoptosis in cancer cells. For example, in February 2024, the World Health Organization predicted that approximately 35 million new cancer cases would be reported in 2050, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising incidence of cancer is driving the histone deacetylase inhibitors market.
Claim Your Free Sample of the Global Histone Deacetylase Inhibitors Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=17170&type=smp
What Segments Are Central to the Histone Deacetylase Inhibitors Market?
The histone deacetylase inhibitors market covered in this report is segmented –
1) By Classification: Class I Histone Deacetylases (HDACs), Class II Histone Deacetylases (HDACs), Class III Histone Deacetylases (HDACs), Other Classifications
2) By Route Of Administration: Oral, Injectable, Other Routes Of Administration
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By Application: Oncology, Neurology, Other Applications
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End Users
What Emerging Trends Are Influencing Histone Deacetylase Inhibitors Industry Dynamics?
Major firms are focused on creating new formulations such as oral histone deacetylase (HDAC) inhibitors to broaden treatment options and enhance patient compliance. An oral HDAC inhibitor is taken to target HDAC enzymes linked to gene regulation, useful for treating diseases like cancer. In March 2024, Italfarmaco S.p.A. received FDA approval for Duvyzat (givinostat), an oral HDAC inhibitor for Duchenne muscular dystrophy (DMD) in patients aged 6 and older. Duvyzat aims to slow muscle deterioration by inhibiting HDAC overactivity, reducing inflammation and promoting muscle regeneration, based on the successful phase 3 EPIDYS trial.
Order Now for Fast Delivery of Your Histone Deacetylase Inhibitors Market Report!
Which Geographic Locations Are Critical to the Growth of the Histone Deacetylase Inhibitors Market?
North America was the largest region in the histone deacetylase inhibitors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the histone deacetylase inhibitors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Histone Deacetylase Inhibitors Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the histone deacetylase inhibitors market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Histone Deacetylase Inhibitors Market Include
1. Histone Deacetylase Inhibitors Market Executive Summary
2. Histone Deacetylase Inhibitors Market Segments
3. Histone Deacetylase Inhibitors Market Size And Template Market Growth Rate
4. Key Histone Deacetylase Inhibitors Market Trends
5. Major Histone Deacetylase Inhibitors Market Drivers
……
25. Key Mergers And Acquisitions In The Histone Deacetylase Inhibitors Market
26. Top Histone Deacetylase Inhibitors Companies
27. Histone Deacetylase Inhibitors Market Opportunities And Strategies
28. Histone Deacetylase Inhibitors Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
HER2 Inhibitors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/her2-inhibitor-global-market-report
Motor Home Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/motor-home-global-market-report
Protein Inhibitors Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/protein-inhibitor-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
